Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Fertility Centre, Lanka Hospitals Corporation Plc, Colombo, Sri Lanka.
Reprod Fertil. 2022 Jul 14;3(3):133-139. doi: 10.1530/RAF-21-0116. eCollection 2022 Jul 1.
The use of intracytoplasmic sperm injection (ICSI) has recently increased worldwide. The live birth rate per ICSI cycle is low, and over half of infertile couples remain childless. Chromosomal polymorphisms are up to five times more common in couples with infertility compared to the general population. We aimed to investigate the association between chromosomal polymorphisms and reproductive outcomes in couples undergoing ICSI treatment. We analysed 942 ICSI fresh and frozen embryo transfer cycles in 697 women who underwent karyotyping analysis using Giemsa-Trypsin-Leishman banding prior to assisted conception at the Fertility Centre of Lanka Hospitals, Sri Lanka, between 2016 and 2018. The primary outcomes were pregnancy, miscarriage, and live birth rates. We compared outcomes according to the presence or absence of chromosomal polymorphism in females, males and couples. There were 294 pregnancies (31.2%) recorded in the study; 130 suffered a miscarriage (13.8%), 13 were ectopic pregnancies (1.3%) and 151 resulted in a live birth (16.0%). The evidence from univariable and multivariable analyses (adjusted for age, BMI, ovarian reserve and treatment type) did not confidently identify a difference in pregnancy, miscarriage or live birth rates between couples with no chromosomal polymorphisms compared to couples where the female, male or both partners were carriers of a chromosomal polymorphism. Further, we did not identify a clear association between the presence of chromosomal polymorphisms and reproductive outcomes compared to participants without chromosomal polymorphisms. Wide CIs precluded the identification of clinically meaningful associations.
Infertility affects approximately one in eight couples worldwide. The use of intracytoplasmic sperm injection (ICSI), where the sperm is directly injected into an egg using a micromanipulator outside the body, has become particularly popular in recent years. However, the success rate remains low. In human cells, the genetic material is arranged in structures called chromosomes. Chromosomal polymorphism is a normal variation where the genetic material is arranged differently to the average individual and is more common in infertile couples compared to the general population. We analysed data from 942 ICSI cycles in 697 couples who underwent karyotyping analysis to assess the changes in chromosomes between 2016 and 2018. The pregnancy rate was 31.2%, with 16.0% of participants experiencing a live birth, while 13.8% of pregnancies resulted in a miscarriage and 1.3% were outside the womb cavity (ectopic). The evidence did not identify a clear association between the chromosomal polymorphism and the outcome of treatment.
胞浆内单精子注射(ICSI)的使用在全球范围内最近有所增加。每个 ICSI 周期的活产率较低,超过一半的不孕夫妇仍无法生育。与普通人群相比,染色体多态性在不孕夫妇中更为常见,多达五倍。我们旨在研究染色体多态性与接受 ICSI 治疗的夫妇的生殖结局之间的关系。我们分析了兰卡医院生育中心在 2016 年至 2018 年期间对 697 名女性进行的 942 个 ICSI 新鲜和冷冻胚胎移植周期的核型分析,这些女性在辅助受孕前使用吉姆萨-胰蛋白酶-利什曼带染色进行了染色体分析。主要结局是妊娠、流产和活产率。我们根据女性、男性和夫妇中是否存在染色体多态性比较了结果。研究中记录了 294 例妊娠(31.2%);130 例流产(13.8%),13 例异位妊娠(1.3%),151 例活产(16.0%)。单变量和多变量分析(根据年龄、BMI、卵巢储备和治疗类型进行调整)的证据并未明确表明与女性、男性或双方伴侣携带染色体多态性的夫妇相比,没有染色体多态性的夫妇的妊娠、流产或活产率存在差异。此外,与没有染色体多态性的参与者相比,我们没有发现染色体多态性的存在与生殖结局之间存在明确的关联。宽置信区间排除了临床有意义关联的识别。
不孕症影响全球约八分之一的夫妇。胞浆内单精子注射(ICSI)的使用尤其流行,其中精子在体外使用微操作器直接注入卵子。然而,成功率仍然很低。在人体细胞中,遗传物质排列在称为染色体的结构中。染色体多态性是一种正常的变异,其中遗传物质的排列方式与平均值不同,与普通人群相比,在不孕夫妇中更为常见。我们分析了 697 对夫妇的 942 个 ICSI 周期的数据,这些夫妇在 2016 年至 2018 年期间进行了核型分析,以评估染色体的变化。妊娠率为 31.2%,16.0%的参与者经历了活产,而 13.8%的妊娠导致流产,1.3%为宫外孕(异位妊娠)。证据并未明确表明染色体多态性与治疗结果之间存在关联。